MetaCap

Nuwellis (NUWE) vs Valion Bio (VBIO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Nuwellis is the larger company by market cap ($1.8 million vs $1.0 million), about 1.8 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

NUWE+393.70%VBIO-78.05%
+797%+339%-120%
Oct 7, 20261 yearNov 20, 2026
NUWE+394.92%VBIO-77.54%
+764%+323%-118%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

NUWE versus VBIO key metrics
MetricNUWEVBIO
Share price$3.41$0.4806
Market cap$1.84M$1.04M
1-day change-10.50%-10.98%
P/E ratio (TTM)0.00—
EPS (TTM)$3,609.63$-177.91
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$8.27M—
Revenue growth (YoY)-5.38%—
Net income (latest FY)$-17.52M$-8.88M
Gross margin61.96%—
Operating margin-134.29%—
Net margin-211.86%—
52-week high$1,556.10$67.50
52-week low$2.52$0.472
Distance from 52-week high-99.78%-99.29%
Average volume829.19K1.78M
Shares outstanding540.91K2.16M
Employees3852
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Nuwellis

NUWE stock →

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 38 employees

About Valion Bio

VBIO stock →

Valion Bio, Inc. operates as a late-stage biopharmaceutical company.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 52 employees

NUWE vs VBIO FAQ

Which is bigger, Nuwellis or Valion Bio?

Nuwellis (NUWE) is larger, with a market capitalization of $1.84M compared with $1.04M for Valion Bio (VBIO).

Are Nuwellis and Valion Bio in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons